Cargando…
Lead Generation and Optimization Based on Protein-Ligand Complementarity
This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264460/ https://www.ncbi.nlm.nih.gov/pubmed/20657448 http://dx.doi.org/10.3390/molecules15064382 |
_version_ | 1783375501843234816 |
---|---|
author | Ogata, Koji Isomura, Tetsu Kawata, Shinji Yamashita, Hiroshi Kubodera, Hideo Wodak, Shoshana J. |
author_facet | Ogata, Koji Isomura, Tetsu Kawata, Shinji Yamashita, Hiroshi Kubodera, Hideo Wodak, Shoshana J. |
author_sort | Ogata, Koji |
collection | PubMed |
description | This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH(3,) NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chemically diverse molecules active against known target proteins. |
format | Online Article Text |
id | pubmed-6264460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62644602018-12-04 Lead Generation and Optimization Based on Protein-Ligand Complementarity Ogata, Koji Isomura, Tetsu Kawata, Shinji Yamashita, Hiroshi Kubodera, Hideo Wodak, Shoshana J. Molecules Article This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH(3,) NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chemically diverse molecules active against known target proteins. MDPI 2010-06-17 /pmc/articles/PMC6264460/ /pubmed/20657448 http://dx.doi.org/10.3390/molecules15064382 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Ogata, Koji Isomura, Tetsu Kawata, Shinji Yamashita, Hiroshi Kubodera, Hideo Wodak, Shoshana J. Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title | Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title_full | Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title_fullStr | Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title_full_unstemmed | Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title_short | Lead Generation and Optimization Based on Protein-Ligand Complementarity |
title_sort | lead generation and optimization based on protein-ligand complementarity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264460/ https://www.ncbi.nlm.nih.gov/pubmed/20657448 http://dx.doi.org/10.3390/molecules15064382 |
work_keys_str_mv | AT ogatakoji leadgenerationandoptimizationbasedonproteinligandcomplementarity AT isomuratetsu leadgenerationandoptimizationbasedonproteinligandcomplementarity AT kawatashinji leadgenerationandoptimizationbasedonproteinligandcomplementarity AT yamashitahiroshi leadgenerationandoptimizationbasedonproteinligandcomplementarity AT kuboderahideo leadgenerationandoptimizationbasedonproteinligandcomplementarity AT wodakshoshanaj leadgenerationandoptimizationbasedonproteinligandcomplementarity |